Here, we newly identify cAMP response element modulator [CREM, also known as inducible cAMP early repressor (ICER)] as a signaling player that links the defect in PKA- and CREB-mediated VEGF production to impaired angiogenesis during the course of diabetes. The gene discussed is CREB1; the disease is diabetes mellitus.